Disease Recurrence and Acute Cellular Rejection Episodes during the First Year after Lung Transplantation among Patients with Sarcoidosis

Transplantation

Volumn 99, Issue 9, 2015, Pages 1940-1945

  Banga, Amit ^a   Sahoo, Debasis ^b   Lane, Charles R ^b   Farver, Carol F ^b   Budev, Marie M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM SURVIVAL; LUNG BIOPSY; LUNG GRAFT REJECTION; LUNG GRANULOMA; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL TIME; TRANSBRONCHIAL BIOPSY; ACUTE DISEASE; ADVERSE EFFECTS; BIOPSY; CELLULAR IMMUNITY; COMPUTER ASSISTED TOMOGRAPHY; FACTUAL DATABASE; GRAFT REJECTION; GRANULOMA, RESPIRATORY TRACT; IMMUNOLOGY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RISK FACTOR; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; ADULT; BIOPSY; BRONCHOSCOPY; DATABASES, FACTUAL; FEMALE; GRAFT REJECTION; GRANULOMA, RESPIRATORY TRACT; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OHIO; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84946944324     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000673     Document Type: Article

References (43)

1. https://www.ishlt.org/registries/heartLungRegistry.asp accessed on April 15, 2014.
2. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14:735-737.
3. Friou GJ. A study of the cutaneous reactions to oidiomycin, trichophytin and mumps skin test antigens in patients with sarcoidosis. Yale J Biol Med. 1952;24:533-539.
4. Sones M, Israel HL. Altered immunological reactions in sarcoidosis. Ann Intern Med. 1954;40:260-268.
5. Christie JD, Edwards LB, Kucheryavaya AY, et al. International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012;31:1073-1086.
6. Walker S, Mikhail G, Banner N, et al. Medium term results of lung transplantation for end stage pulmonary sarcoidosis. Thorax. 1998;53:281-284.
7. Wille KM, Gaggar A, Hajari AS, et al. Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:117-124.
8. Nunley DR, Hattler B, Keenan RJ, et al. Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:93-100.
9. Johnson BA, Duncan SR, Ohori NP, et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis. 1993;148:1373-1377.
10. Bjørtuft O, Foerster A, Boe J, Geiran O. Single lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient. J Heart Lung Transplant. 1994;13:24-29.
11. Martinez FJ, Orens JB, Deeb M, Brunsting LA, Flint A, Lynch JP 3rd. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest. 1994;106:1597-1599.
12. Carré P, Rouquette I, Durand D, et al. Recurrence of sarcoidosis in a human lung allograft. Transplant Proc. 1995;27:1686.
13. Yeatman M, McNeil K, Smith JA, et al. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. J Heart Lung Transplant. 1996;15:144-149.
14. Müller C, Briegel J, Haller M, et al. Sarcoidosis recurrence following lung transplantation. Transplantation. 1996;61:1117-1119.
15. Martel S, Carré PC, Carrera G, Pipy B, Leóphonte PJ. Tumour necrosis factor-alpha gene expression by alveolar macrophages in human lung allograft recipient with recurrence of sarcoidosis: Toulouse Lung Transplantation Group. Eur Respir J. 1996;9:1087-1089.
16. Kiatboonsri C, Resnick SC, Chan KM, et al. The detection of recurrent sarcoidosis by FDG-PET in a lung transplant recipient. West J Med. 1998;168:130-132.
17. Ionescu DN, Hunt JL, Lomago D, Yousem SA. Recurrent sarcoidosis in lung transplant allografts: granulomas are of recipient origin. Diagn Mol Pathol. 2005;14:140-145.
18. International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). Am J Respir Crit Care Med. 1998;158:335-339.
19. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229-1242.
20. Padilla ML, Schilero GJ, Teirstein AS. Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14:16-22.
21. Collins J, Hartman MJ, Warner TF, et al. Frequency and CT findings of recurrent disease after lung transplantation. Radiology. 2001;219:503-509.
22. Mann DM, Fyfe B, Osband AJ, et al. Sarcoidosis within a renal allograft: a case report and review of the literature. Transplant Proc. 2013;45:838-841.
23. Vanatta JM, Modanlou KA, Dean AG, et al. Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl. 2011;17:1027-1034.
24. Perkel D, Czer LS, Morrissey RP, et al. Heart transplantation for end-stage heart failure due to cardiac sarcoidosis. Transplant Proc. 2013;45:2384-2386.
25. Chang TI, Chi NH, Chou NK, et al. Isolated cardiac sarcoidosis in heart transplantation. Transplant Proc. 2012;44:903-906.
26. Brill AK, Ott SR, Geiser T. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study. Respiration. 2013;86:376-383.
27. Banga A, Gildea T, Rajeswaran J, Rokadia H, Blackstone EH, Stoller JK. The natural history of lung function after lung transplantation for (1)-antitrypsin deficiency. Am J Respir Crit Care Med. 2014;190:274-281.
28. Milman N, Burton C, Andersen CB, Carlsen J, Iversen M. Lung transplantation for end-stage pulmonary sarcoidosis: outcome in a series of seven consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22:222-228.
29. Gabrilovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med. 1996;2:1096-1103.
30. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci USA. 2004;101:7669-7674.
31. Mariotti S, Teloni R, Iona E, et al.Mycobacteriumtuberculosis subverts the differentiation of human monocytes into dendritic cells. Eur J Immunol. 2002;32:3050-3058.
32. Ratta M, Fagnoni F, Curti A, et al. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood. 2002;100:230-237.
33. Satthaporn S, Robins A, Vassanasiri W, et al. Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol Immunother. 2004;53:510-518.
34. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7:610-621.
35. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
36. Lechler RI, Ng WF, Steinman RM. Dendritic cells in transplantation-friend or foe Immunity. 2001;14:357-368.
37. Solari MG, Thomson AW. Human dendritic cells and transplant outcome. Transplantation. 2008;85:1513.
38. Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol. 2010;108:111-165.
39. Pulendran B, Tang H, Manicassamy S. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol. 2010;11:647-655.
40. Shodell M, Shah K, Siegal FP. Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus. 2003;12:222-230.
41. BartenMJ, Garbade J, Bittner HB, et al. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation. Int Immunopharmacol. 2006;6:2011-2017.
42. Bizargity P, Liu K, Wang L, Hancock WW, Visner GA. Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection. Transplantation. 2012;94:114-122.
43. Mathew S, Bauer KL, Fischoeder A, Bhardwaj N, Oliver SJ. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol. 2008;181:746-755.